Highlights from SLAS San Diego

18 February 2016

Aubrey Woodroof, founder and CEO of PermeaDerm, describes innovative skin substitutes, designed for severe burn and chronic wound treatment. He explains how BioDot technology, used in collaboration with researchers at the University of Rochester, has enhanced the accuracy and efficiency of the manufacturing process for a new, advanced skin substitute. Visit PermeaDerm for further information.